These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 19552854)

  • 1. The effectiveness of prophylaxis for measles contacts in NSW.
    Sheppeard V; Forssman B; Ferson MJ; Moreira C; Campbell-Lloyd S; Dwyer DE; McAnulty JM
    N S W Public Health Bull; 2009; 20(5-6):81-5. PubMed ID: 19552854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles vaccination effectiveness among children under 5 years of age in Kampala, Uganda.
    Mupere E; Karamagi C; Zirembuzi G; Grabowsky M; de Swart RL; Nanyunja M; Mayanja H
    Vaccine; 2006 May; 24(19):4111-5. PubMed ID: 16554111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An outbreak of measles in a rural Queensland town in 1997; an opportunity to assess vaccine effectiveness.
    Gidding HF; Hills S; Selvey L; Roberts LA; Johnston S
    Commun Dis Intell; 1999 Sep; 23(9):240-5. PubMed ID: 10554408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A measles epidemic controlled by immunisation.
    Mansoor O; Blakely T; Baker M; Tobias M; Bloomfield A
    N Z Med J; 1998 Dec; 111(1079):467-71. PubMed ID: 9972200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large outbreak of measles in a community with high vaccination coverage: implications for the vaccination schedule.
    Domínguez A; Torner N; Barrabeig I; Rovira A; Rius C; Cayla J; Plasencia E; Minguell S; Sala MR; Martínez A; Costa J; Mosquera M; Cabezas C;
    Clin Infect Dis; 2008 Nov; 47(9):1143-9. PubMed ID: 18823269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimated protective effectiveness of intramuscular immune serum globulin post-exposure prophylaxis during a measles outbreak in British Columbia, Canada, 2014.
    Bigham M; Murti M; Fung C; Hemming F; Loadman S; Stam R; Van Buynder P; Lem M
    Vaccine; 2017 May; 35(20):2723-2727. PubMed ID: 28392140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epidemiological characteristics of measles in mass vaccine prophylaxis and the prospects for its eradication].
    Smorodintsev AA; Rykushin IuP; Smorodintsev AlA
    Tr Inst Im Pastera; 1982; 57():10-6. PubMed ID: 6221441
    [No Abstract]   [Full Text] [Related]  

  • 8. Ongoing measles outbreak in Wallonia, Belgium, December 2016 to March 2017: characteristics and challenges.
    Grammens T; Schirvel C; Leenen S; Shodu N; Hutse V; Mendes da Costa E; Sabbe M
    Euro Surveill; 2017 Apr; 22(17):. PubMed ID: 28488998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measles outbreak in Qassim, Saudi Arabia 2007: epidemiology and evaluation of outbreak response.
    Jahan S; Al Saigul AM; Abu Baker MA; Alataya AO; Hamed SA
    J Public Health (Oxf); 2008 Dec; 30(4):384-90. PubMed ID: 18716046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impacts of a measles outbreak in Western Sydney on public health resources.
    Flego KL; Belshaw DA; Sheppeard V; Weston KM
    Commun Dis Intell Q Rep; 2013 Sep; 37(3):E240-5. PubMed ID: 24890960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained outbreak of measles in New South Wales, 2012: risks for measles elimination in Australia.
    Najjar Z; Hope K; Clark P; Nguyen O; Rosewell A; Conaty S
    Western Pac Surveill Response J; 2014; 5(1):14-20. PubMed ID: 25635228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Basis for the need for mass revaccination against measles and results of conducting it].
    Rykushin IuP; Deshevoĭ SE
    Tr Inst Im Pastera; 1992; 67():96-102. PubMed ID: 8539773
    [No Abstract]   [Full Text] [Related]  

  • 13. Field effectiveness of hepatitis A vaccine and uptake of post exposure prophylaxis following a change to the Australian guidelines.
    Freeman E; Lawrence G; McAnulty J; Tobin S; MacIntyre CR; Torvaldsen S
    Vaccine; 2014 Sep; 32(42):5509-13. PubMed ID: 25111168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlling measles in NSW: how are we doing in the context of other countries in the Western Pacific?
    Menzies RI; Burgess M; Durrheim DN
    N S W Public Health Bull; 2012 Dec; 23(9-10):169-70. PubMed ID: 23442993
    [No Abstract]   [Full Text] [Related]  

  • 15. Current efficacy of postexposure prophylaxis against measles with immunoglobulin.
    Endo A; Izumi H; Miyashita M; Taniguchi K; Okubo O; Harada K
    J Pediatr; 2001 Jun; 138(6):926-8. PubMed ID: 11391343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Outbreak of measles in Mayotte, Indian Ocean, 2005-2006].
    D'Ortenzio E; Sissoko D; Landreau D; Benoit-Cattin T; Renault P; Pierre V
    Med Mal Infect; 2008 Nov; 38(11):601-7. PubMed ID: 18722725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of measles outbreak response vaccination campaign in Dar es Salaam, Tanzania.
    Goodson JL; Wiesen E; Perry RT; Mach O; Kitambi M; Kibona M; Luman ET; Cairns KL
    Vaccine; 2009 Sep; 27(42):5870-4. PubMed ID: 19656496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rural Kenya: measles during pregnancy and early infancy.
    Arya SC; Agarwal N
    J Infect Dis; 2006 Jan; 193(1):165-6; author reply 166-7. PubMed ID: 16323147
    [No Abstract]   [Full Text] [Related]  

  • 19. Summary and conclusions: measles elimination meeting, 16-17 March 2000.
    Katz SL; Hinman AR
    J Infect Dis; 2004 May; 189 Suppl 1():S43-7. PubMed ID: 15106088
    [No Abstract]   [Full Text] [Related]  

  • 20. Nationwide measles epidemic in Ukraine: the effect of low vaccine effectiveness.
    Velicko I; Müller LL; Pebody R; Gergonne B; Aidyralieva C; Kostiuchenko N; Spika JS
    Vaccine; 2008 Dec; 26(52):6980-5. PubMed ID: 18805455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.